A study on the prevention of hemorrhage and perforation in patients with primary gastric diffuse large-B cell lymphoma during treatment with immunochemotherapy.
Limei ZhangHe HuangZhao WangXiaojie FangHuangming HongYungchang ChenQuanguang RenYuyi YaoZegeng ChenFei PanXiaoqian LiMei-Ting ChenTongyu LinPublished in: Cancer medicine (2023)
Preventative treatment can decrease the risk of hemorrhage and perforation in patients with localized PG-DLBCL during immunochemotherapy, leading to better EFS and OS in these patients. However, preventative treatment failed to reduce the risk of gastric hemorrhage and perforation and did not improve survival (EFS and OS) in advanced-stage patients.